Explore Our Publications

At Magnolia Innovation, we are constantly striving to contribute meaningful data and analysis to the larger healthcare conversation.

Below are some of the independent and collaborative publications we have worked on recently.

COVID-19: Impact on the Rare Disease Community

Learn the ways pharma can empower rare disease patients during the uncertainty of the COVID-19 Pandemic

oncologist segmentation cover

COVID-19: Impact on the Rare Disease Community

Learn the ways pharma can empower rare disease patients during the uncertainty of the COVID-19 Pandemic

oncologist segmentation cover

Oncologist Segmentation

Learn how to tailor personal and non-personal promotion based on attitudinal differences among oncologists

oncologist segmentation cover

Oncologist Segmentation

Learn how to tailor personal and non-personal promotion based on attitudinal differences among oncologists

oncologist segmentation cover

Benchmarking the COVID-19 Pandemic

Explore key lessons from other historical events to inform effective ways to manage the COVID-19 pandemic

oncologist segmentation cover

Benchmarking the COVID-19 Pandemic

Explore key lessons from other historical events to inform effective ways to manage the COVID-19 pandemic

oncologist segmentation cover

The Hidden Burden

Optimize commercial efforts by understanding the common challenges in the rare disease landscape

oncologist segmentation cover

The Hidden Burden

Optimize commercial efforts by understanding the common challenges in the rare disease landscape

oncologist segmentation cover

Understanding the Burden of Primary Hyperoxaluria Type 1 (Ph1)

Understand the debilitating effects of Ph1 to identify the opportunities for earlier diagnosis and effective therapies

oncologist segmentation cover

Understanding the Burden of Primary Hyperoxaluria Type 1 (Ph1)

Understand the debilitating effects of Ph1 to identify the opportunities for earlier diagnosis and effective therapies

oncologist segmentation cover